|Bid||7,116.00 x 0|
|Ask||7,122.00 x 0|
|Day's range||6,958.00 - 7,150.00|
|52-week range||5,130.00 - 8,191.30|
|Beta (5Y monthly)||0.23|
|PE ratio (TTM)||N/A|
|Earnings date||28 Jul 2020|
|Forward dividend & yield||2.03 (2.90%)|
|Ex-dividend date||16 Apr 2020|
|1y target est||7,085.56|
As China’s Hubei province was locked down in January, weeks after coronavirus emerged in the capital Wuhan, frantic efforts were made to keep one local factory running. Reckitt Benckiser’s second-largest Dettol plant worldwide is in the city of Jingzhou, just over 200km from Wuhan, the centre of the virus outbreak. The Hubei factory, which usually exports around 20 per cent of its output, mainly to Japan and Europe, has increased its daily capacity from 40 tonnes to more than 400 during the pandemic.
Dividend paying stocks like Reckitt Benckiser Group plc (LON:RB.) tend to be popular with investors, and for good...
(Bloomberg) -- The viral pandemic sweeping the globe sent Lysol-maker Reckitt Benckiser Group Plc to its strongest start to the year in recent memory.Sales jumped 13.5% in the first quarter, crushing estimates and prompting the Slough, England-based company to raise its outlook for the year. The shares rose the most in six weeks.As demand soars, Reckitt is ramping up production, Chief Executive Officer Laxman Narasimhan said on a conference call. “To give you one example: In the coming month of May -- in one month -- we’ll produce all the sanitizers we produced in 2019, for the whole year.”Disinfectants became an object of social media fascination last week after President Donald Trump spoke of their effectiveness in killing the virus on surfaces, and even mused over whether cleansers could be used to treat Covid-19.That prompted Reckitt to take the unusual step of publishing a statement warning that “under no circumstance” should its disinfectants be administered into the human body, through injection, ingestion or any other route.Reckitt Warns Against Using Disinfectants to Treat CoronavirusReckitt has pushed its factories to meet unprecedented demand as the pandemic spread from Asia to Europe and the U.S. Lysol sales surged by more than 50% in North America, buoyed in March as the health crisis became more pronounced in the region.At the company’s over-the-counter medicine business, sales grew by about a third during the quarter, driven by demand for cold and flu remedies such as Mucinex, which work to relieve some of the same early flu-like symptoms of the Covid-19 disease.Narasimhan said it’s too soon to say whether the increase in demand seen in March and April will be sustained, and warned that the coronavirus could create further challenges in some markets.”As consumers operate in this kind of environment, over time, behaviors become quite ingrained” he said. “Our expectation is that there’s a reinforcement of the idea of hygiene being the foundation of health.”Get MoreSee more details.Read the statement.(Recasts first three paragraphs)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
The U.S. death toll and COVID-19 cases climbed, as arguments flared over coronavirus treatments and the path to restarting the economy.
Reckitt Benckiser Group plc (LON:RB.) is about to trade ex-dividend in the next 3 days. You will need to purchase...
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Could Reckitt Benckiser Group plc (LON:RB.) be an attractive dividend share to own for the long haul? Investors are...
Investors who take an interest in Reckitt Benckiser Group plc (LON:RB.) should definitely note that the Chief...
The big shareholder groups in Reckitt Benckiser Group plc (LON:RB.) have power over the company. Insiders often own a...
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...